Doctor Goldstein, MD
Molecular Genetic Pathology · Bronx, NYNPI 1295014991
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Cepheid at 50.4% of the total. Reporting peaked in 2023 at $18,513 and has fallen 98.0% since, to $368 in 2025.
Across 70 payments — averaging $517.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cepheid$18K
- Roche Diagnostics Corporation$15K
- Qiagen, LLC$2K
- Beckman Coulter, Inc.$351
- BD$250
- Abbott$224
- plus $51 from 1 others
Across 1 payment — averaging $37,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$38K
What the payments were for
- Consulting fees$2,6487%
- Speaking & faculty fees$17,00047%
- Travel & lodging$15,46343%
- Food & beverage$1,1203%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cepheid | 32 | $18,261 |
| Roche Diagnostics Corporation | 13 | $15,025 |
| Qiagen, LLC | 4 | $2,069 |
| Beckman Coulter, Inc. | 10 | $351 |
| BD | 1 | $250 |
| Abbott | 8 | $224 |
| Hologic Sales And Service, LLC | 2 | $51 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENEXPERT$17,972
- BCM for cobas 8100$10,122
- cobas pro ISE analytical unit$2,202
- DXH 900 Hematology System$117
How this compares
Too few molecular genetic pathology providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other molecular genetic pathology in Bronx
- Robert BurkBronx$5K
- Mark EwaltNew York$38K
- James SolomonNew York$14K
- Sanjay MukhopadhyaySyracuse$2K
- Tatyana GindinNew York$1K
- Chad VanderbiltNew York$290
- Jamal BenhamidaNew York$283
- Shella MongiaRoslyn$271
- Christian EzidiegwuSyracuse$181
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.